4-Methylmorpholine-2-carboxylic acid hydrochloride

Catalog No.: 
ACZSAR217
CAS No.: 
841274-05-3
Molecular Formula: 
C6H12ClNO3
Molecular Weight: 
181.62
4-Methylmorpholine-2-carboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$81.00InquiryInquiry
100mg95%$109.00InquiryInquiry
250mg95%$151.00InquiryInquiry
1g95%$286.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methylmorpholine-2-carboxylic acid hydrochloride
IUPAC Name4-methylmorpholine-2-carboxylic acid hydrochloride
MDL No.MFCD06738959
Molecular FormulaC6H12ClNO3
Molecular Weight181.62
SMILESO=C(C1CN(C)CCO1)O.[H]Cl
InChI KeyHWHCYNGGRABGQT-UHFFFAOYSA-N
Synonym4-METHYL-MORPHOLINE-2-CARBOXYLIC ACID HYDROCHLORIDE;2-CARBOXY-4-METHYL-MORPHOLINE HCL;4-Methyl-2-morpholinecarboxylic acid HCl;2-Morpholinecarboxylic acid, 4-methyl-, hydrochloride
CAS No.841274-05-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZSAR217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMYBD156 route compound structure diagram
    ACMYBD156300582-83-6In Stock
  4. Then
  5. ACZSAR217 route product structure diagram
    ACZSAR217841274-05-3
Inquiry

2. ACZSAR217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZSAR217 route product structure diagram
    ACZSAR217841274-05-3
Inquiry

3. ACZSAR217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZSAR217 route product structure diagram
    ACZSAR217841274-05-3
Inquiry

Comments (0)